GlaxoSmithKline's Boston Braves Hat
(R)ApexiCon and ClindaMax are registered trademarks, and (TM)LoKara is a trademark of PharmaDerm, a division of ALTANA Inc.
The acquisition marks an expansion of PharmaDerm's current portfolio, which includes flagship products ApexiCon E Cream(R) (diflorasone diacetate cream USP, 0.05% [emollient]) for steroid responsive dermatoses such as eczema, psoriasis and contact dermatitis, and ClindaMax(R) Lotion (clindamycin phosphate topical suspension USP, 1%), for the treatment of acne. "This acquisition represents our ongoing commitment to expand our business by providing dermatologists with additional solutions for their patients' needs," said Malcolm McCoy, Vice President of Sales and Marketing at PharmaDerm. "The addition of new product lines allows us to significantly enhance our existing sales and marketing capability and to broaden our offering to the dermatology marketplace."
certainty, may cause actual results to vary substantially from those specifically or implicitly expected in these statements.
30 /PRNewswire/ . New Era Seattle Mariners
1 Acquires US Dermatology Business From 2 Consumer Healthcare
In March 2005, GlaxoSmithKline received FDA approval for Cutivate(R) Lotion. Yet to mark its official launch, Cutivate Lotion will add a valuable exclusive asset to PharmaDerm's product Kansas City Athletics Hat portfolio. "We will move forward with plans to launch Cutivate Lotion this fall and are especially excited about offering dermatologists an effective, mid potency steroid for their adult and pediatric patients," McCoy added. Financial terms of the deal were not disclosed. subsidiaries of ALTANA Pharma AG, an international pharmaceutical company headquartered in Germany. ALTANA Inc is the managing group for four divisions including: Fougera and PharmaDerm, which produce topical dermatologic ointments and creams; Pharmaderm Animal Health, a manufacturer of topical preparations for animal care, and Savage Laboratories, marketers of the antidotes CroFab(TM) and DigiFab(R) for hospital emergency medicine departments.
Cytokinetics, Inc. (CYTK) Has Mixed Results In Phase II TrialSalix Pharmaceuticals, Ltd. (SLXP) Announces Approval of Merger With InKine Pharmaceutical Company, Inc. (INKP)
ALTANA Inc, a wholly owned subsidiary of ALTANA Pharma AG, announced today that it has acquired the prescription dermatology business from GlaxoSmithKline Consumer Healthcare, a division of GlaxoSmithKline Corporation . PharmaDerm, a division of ALTANA Inc, will manufacture and market the former GSK products to include:
(GSK) Paxil Linked To Birth DefectsActavis Acquires Keri Pharma Generics As Part Of Its Expansion Strategy In The CEE RegionALTANA Inc. (AAA) Inaugurates 100,000 SQ. FT. Of Manufacturing Space In Hicksville, New YorkNovoste (NOVT) Terminates $32 Million Merger Agreement With ONI, Inc.
"This transaction represents a key acquisition on the branded side of our business and supports the ALTANA Inc specialty business. It is a significant step in the formation of PharmaDerm and toward achieving our goal of becoming the leading pharmaceutical company specializing in dermatology," said Paul B. McGarty, Chief Executive Officer of ALTANA Inc.
Statements about the organization's future expectations, other than historical facts, are "forward looking statements," based on appraisals by the PharmaDerm management and information currently available to PharmaDerm. Factors, which PharmaDerm cannot predict with Denver Nuggets Hats
2005 PharmaDerm, Norcross, GA.
See product packaging inserts for full prescribing information.
Air Jordan Cap Black
New Era 59fifty Limited Edition
Brooklyn Dodgers Cap
Colorado Rockies Caps
Jordan Cap Youth
Gucci Belt Double G Black
Ny Caps Red
Chicago Cubs Hats
Louis Vuitton Belt V
Gucci Belt Men Tiger
Hermes Belt Price For Men
Kansas City Royals Hat
Ferragamo Belt Limited Edition
New Era 9fifty Original Fit